Tag Archives: therascreen EGFR companion diagnostic

QIAGEN N.V. released Q2 and H1 2013 results and announced new share repurchase program

Q2 2013 results: Adjusted net sales of $316.4 million (+3% CER) on growth in all regions; adjusted operating income of $83.4 million; adjusted diluted EPS of $0.27 per shareNew program authorized to repurchase up to $100 million in QIAGEN shares … Read the full press release